Crossmark

Successful Long-Term Treatment Combining Omalizumab and Anti-IL-5 Biologics in Allergic Bronchopulmonary Aspergillosis

Crossref DOI link: https://doi.org/10.1016/j.arbres.2021.12.005

Published Print: 2022-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Laorden, Daniel

Zamarrón, Ester

Domínguez-Ortega, Javier

Romero, David

Quirce, Santiago

Álvarez-Sala, Rodolfo
License Information

Text and Data Mining valid from 2022-08-01
More Information

This article is maintained by: Elsevier

Article Title: Successful Long-Term Treatment Combining Omalizumab and Anti-IL-5 Biologics in Allergic Bronchopulmonary Aspergillosis

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2021.12.005

Content Type: simple-article

Copyright: © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.